TVGN stock price decline followed by recovery

TVGN fell on 2024-05-24 as the company announced [1] a $36 million line of credit and potential $14 million private placements which led to concerns about [2] cash position and funding needs for R&D and clinical trials according to [5] analysts from Jones Trading and Oppenheimer. However, more recently in [3] and [4], the company secured up to $50 million in total financing through the $36 million credit line and $14 million private placement which reassured investors about funding and removed previous concerns.